Cannabis strains (cultivars) cause plenty of debate. Seeds from a single variety can express a multitude of phenotypes and profiles. And clones of a single phenotype can mutate and succumb to change. Terpene and cannabinoid profiles can, however, be kept consistent down a long lineage of generations, clone after clone. In fact, genetic stability has […]

The post Clones are consistent enough to prove cannabis is medicine, sometimes appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Excipients Market Size, Trends & Growth Opportunity, By product, By Formulations, Region and Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The global pharmaceutical excipients market is expected to grow from $8.3 billion in 2021 to $10.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.0% […]

The post The Worldwide Pharmaceutical Excipients Industry is Expected to Reach $10.6 Billion by 2027 – ResearchAndMarkets.com appeared first on Fintech News.

Psilocybin’s therapeutic benefits have been recognized by the medical industry too. The Johns Hopkins Center for Psychedelic and Consciousness Research has invested in a psychedelic and psilocybin therapy and research center, thanks to $17 million in funding, so that researchers can learn more about psychedelics, how they can help treat illness, and develop new treatments for behavioral disorders.

U.S. Circuit Judge Timothy B. Dyk has unsealed his opinion in a Delaware federal court case explaining why he found a Takeda Pharmaceutical Co. Ltd. unit's antibody patent was too broad to meet the enablement requirement, ultimately letting Roche subsidiary Genentech off the hook for infringing with its blockbuster hemophilia drug Hemlibra.

In this post, we bring to you few Patent Cases decided by Indian Courts in the year 2021 Merck Sharp And Dohme Corp & ANR vs YMS Laboratories Private Limited In this case, the plaintiff, owner of patents pertaining to Sitagliptin and its derivative salts, filed an infringement suit against the defendant. The plaintiff prayed for an Ad Interim Injunction during the pendency of the suit. After reviewing the facts presented, the Court granted an Exparte Ad Interim Injunction as…

The post Recap 2021- Indian Patent Case Laws appeared first on BananaIP Counsels.

You read it right! No, it’s not a real legalization, or even decriminalization. But for two years, Rhode Island is operating a pilot program with safe use sites that allows legal drug use. What will come after is hard to say, but for now, here are some details of this kind of cool – and […]

The post Rhode Island 1st State to Open Safe Use Sites for Drugs appeared first on CBD Testers.

DUBLIN–(BUSINESS WIRE)–The “CBD Consumer Health Market Research Report by Product, by Distribution Channel, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global CBD Consumer Health Market size was estimated at USD 6,924.40 million in 2020, is expected to reach USD 7,912.67 million in […]

Clinicians can use the algorithm to quickly identify if the Breating Tube is properly positioned.

The post FDA grants 510(k) clearance to Qure.ai’s artificial intelligence algorithm appeared first on Medical Device Network.

Camardo to lead Company’s transition to a commercial-stage company CLEVELAND–(BUSINESS WIRE)–$ATHX #Athersys–Athersys, Inc. (Nasdaq: ATHX), an international, late-stage, regenerative medicine company, announced today the appointment of Daniel A. Camardo as the Company’s Chief Executive Officer, effective February 14, 2022. Mr. Camardo is a senior pharmaceutical and biotech executive with more than 25 years of commercial […]

The post Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer appeared first on Fintech News.

AOP Orphan has asked authorities in Germany to investigate allegedly deceptive statements a Taiwanese drug developer made during arbitration over an ill-fated deal to develop a new blood cancer treatment, including a proceeding in which the Austrian pharmaceutical company was awarded €140 million.

Three recent False Claims Act cases in federal district courts, pursuing the novel theory that pharmaceutical companies defrauded the government by charging inflated drug prices based on invalid patents, could set federal appellate courts on a collision course and create new risks for patent holders, say attorneys at Williams & Connolly.

We’re pleased to inform you that LexisNexis has released its inaugural ‘Innovation Momentum 2022: The Global Top 100’ report. For further details, please see their announcement below: LexisNexis recognizes the world’s outperforming companies with its “Innovation Momentum 2022: The Global Top 100” report The first patent-based report to measure short-term innovation momentum, highlighting innovators with exceptional technological relevance for the future. To uncover forward-thinking patent development and spotlight true technological contemporaries across industries, LexisNexis Intellectual Property Solutions has released its inaugural...